tirzepatide glendale az Weight Loss Clinic Medical Weight Loss GLP-1 in

Genotyping DNA was extracted from whole blood samples from participants enrolled in the SURMOUNT-1 trial (supported by Eli Lilly and Company

Subcutaneous injection (pre-filled pen)

From there, the dose can be increased in 2.5 milligram increments every four weeks based on individual response and tolerability

What you get Your plan includes everything

Sources Can multiple Mounjaro (tirzepatide) injections be combined to make a larger dose

The SURMOUNT-1 trial showed that patients who discontinued medication after 72 weeks regained approximately 14% of their body weight over the next 52 weeks (Aronne et al., JAMA 2024)